Trade Summary

6 days ago, Dickinson Andrew D, serving as CFO at Gilead Sciences, Inc. (GILD), sold 3,000 shares at $132.27 per share, for a total transaction value of $396,810.00. Following this transaction, Dickinson Andrew D now holds 173,191 shares of GILD.

This sale represents a 2.00% decrease in Dickinson Andrew D's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 5:50 PM ET, 3 days after the trade was made.

Gilead Sciences, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.